Creative Medical Technology Holdings Inc
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $7.31 million
- Book Value:
- Revenue TTM:
- Operating Margin TTM:
- Gross Profit TTM:
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Creative Medical Technology Holdings Inc had its IPO on 2015-11-06 under the ticker symbol CELZ.
The company operates in the Healthcare sector and Biotechnology industry. Creative Medical Technology Holdings Inc has a staff strength of 4 employees.
Shares of Creative Medical Technology Holdings Inc opened at $0.51 at the start of the last trading session i.e. 2023-03-29.
The stocks traded within a range of $0.49 - $0.54, and closed at $0.5.
This is a -3.87% slip from the previous day's closing price.
A total volume of 213,077 shares were traded at the close of the day’s session.
In the last one week, shares of Creative Medical Technology Holdings Inc have slipped by -6.27%.
Creative Medical Technology Holdings Inc's Key Ratios
Creative Medical Technology Holdings Inc has a market cap of $7.31 million, indicating a price to book ratio of 0.2311 and a price to sales ratio of 37.9816.
In the last 12-months Creative Medical Technology Holdings Inc’s revenue was $137754 with a gross profit of $39805 and an EBITDA of $-5347078. The EBITDA ratio measures Creative Medical Technology Holdings Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Creative Medical Technology Holdings Inc’s operating margin was -3948.46% while its return on assets stood at -26.56% with a return of equity of -71.9%.
In Q3, Creative Medical Technology Holdings Inc’s quarterly earnings growth was a positive 358.9% while revenue growth was a positive 450%.
Creative Medical Technology Holdings Inc’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $-5.25 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Creative Medical Technology Holdings Inc’s profitability.
Creative Medical Technology Holdings Inc stock is trading at a EV to sales ratio of 39.6963 and a EV to EBITDA ratio of -1.03. Its price to sales ratio in the trailing 12-months stood at 37.9816.
Creative Medical Technology Holdings Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $22.47 million
- Total Liabilities
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
Creative Medical Technology Holdings Inc ended 2023 with $22.47 million in total assets and $0 in total liabilities. Its intangible assets were valued at $22.47 million while shareholder equity stood at $22.07 million.
Creative Medical Technology Holdings Inc ended 2023 with $0 in deferred long-term liabilities, $396957.00 in other current liabilities, 14077.00 in common stock, $-47596166.00 in retained earnings and $0 in goodwill. Its cash balance stood at $21.99 million and cash and short-term investments were $21.99 million. The company’s total short-term debt was $0 while long-term debt stood at $0.
Creative Medical Technology Holdings Inc’s total current assets stands at $22.01 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0.00 compared to accounts payable of $327843.00 and inventory worth $15894.00.
In 2023, Creative Medical Technology Holdings Inc's operating cash flow was $-5021307.00 while its capital expenditure stood at $0.
Comparatively, Creative Medical Technology Holdings Inc paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Creative Medical Technology Holdings Inc stock is currently trading at $0.5 per share. It touched a 52-week high of $4.5 and a 52-week low of $4.5. Analysts tracking the stock have a 12-month average target price of $10.
Its 50-day moving average was $0.6 and 200-day moving average was $0.56 The short ratio stood at 0.35 indicating a short percent outstanding of 0%.
Around 254% of the company’s stock are held by insiders while 776.9% are held by institutions.
Frequently Asked Questions About Creative Medical Technology Holdings Inc
Similar Industry Stocks (Biotechnology)
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.